{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-25-000058","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.851040+00:00","generated_at":"2026-05-16T20:53:55.662895+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pulmonx Q3 rev $21.5M (+5%), net loss $14.0M; guides FY rev $89-90M; adds COO role","bullets":["Worldwide revenue $21.5M (+5% YoY); US $14.0M (+1%), Intl $7.5M (+15%).","Gross margin 75% vs 74% YoY; net loss $14.0M ($0.34/share) vs $14.1M ($0.36) YoY.","Adjusted EBITDA loss $8.2M vs $8.1M YoY; cash $76.5M.","FY2025 revenue guidance narrowed to $89-90M; operating expenses $125-126M incl ~$21M SBC.","Glen French reappointed CEO; Derrick Sung appointed COO & CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-25-000058","json":"https://secwatch.observer/filing/0001127537-25-000058.json","markdown":"https://secwatch.observer/filing/0001127537-25-000058.md","text":"https://secwatch.observer/filing/0001127537-25-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753725000058/0001127537-25-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753725000058/lung-20251112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:53:55.662895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}